MedPath

CAVERJECT STERILE POWDER

CAVERJECT STERILE POWDER

Approved
DIN Number

02215756

Drug Class

Human

Market Date

Aug 29, 1997

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02215756
AIG Number0115288006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BE01 ALPROSTADIL
Product Specifications
Dosage FormPowder For Solution ,  Liquid ,  Kit
Route of AdministrationIntracavernosal
AHFS Classification24:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ALPROSTADILActive
Strength: 20 MCG / VIAL
Monograph: ALPROSTADIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.